Target intelligence / Profile preview

Desmosomal protein (keratinocyte)

Molecular classification
Other (Adhesion molecule complex)
01

Overview

Desmosomal proteins in keratinocytes are a group of cell-adhesion molecules and associated adaptor proteins that form desmosomes—specialized intercellular junctions crucial for providing mechanical strength and stability to the epidermis. Core desmosomal proteins include the transmembrane cadherins (desmogleins and desmocollins) and members of the armadillo family (plakoglobin and plakophilins), which interact with desmoplakin to link the junctional complex to the keratin intermediate filament cytoskeleton[2][3][5]. These structures are essential for maintaining strong cell–cell adhesion in tissues subject to mechanical stress, such as the skin. Defects or autoimmunity against these proteins are implicated in skin blistering diseases (e.g., pemphigus), hereditary disorders (e.g., Darier disease), and certain cardiomyopathies[1][2][6]. Targeting individual desmosomal proteins (such as DSG3 in pemphigus) has therapeutic implications, though the protein complex as a whole is not typically a drug target but rather a critical biological structure. Important note on specificity/accuracy: "Desmosomal proteins in keratinocytes" is not a single molecule or receptor but refers to a family of structurally and functionally interconnected proteins forming the desmosome. For structured data, it is preferable to treat each major component protein (e.g., desmoglein 3, desmocollin 1, plakoglobin, desmoplakin) as an individual target. This entry describes the protein group as a whole, but lack of specificity may limit biomedical or pharmacological utility[2][5].

Other names
Desmosomal componentDesmosomal cadherinDesmosomal plaque proteinKeratinocyte desmosomal proteins
02

Biological functions

Cell adhesionMaintenance of tissue integrityStructural supportMechanical strength for epithelia
03

Disease associations

Skin diseases (e.g., pemphigus, Darier disease)Cardiac diseases (e.g., arrhythmogenic right ventricular cardiomyopathy)CancerOther (epithelial barrier disorders)
04

Safety considerations

Disruption can cause loss of epithelial integrityAutoantibody-mediated diseases (e.g., pemphigus vulgaris)Adverse impact on wound healing or barrier recovery if targeted

Beyond the preview

Go deeper on Desmosomal protein (keratinocyte).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desmosomal protein (keratinocyte).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call